Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Xiao-I Corporation (AIXI) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings
Bronstein, Gewirtz & Grossman, is investigating potential claims against Xiao-I (NASDAQ: AIXI) on behalf of investors who purchased the company's securities. The investigation focuses on the significant drop in Xiao-I's ADS price since its IPO on March 8, 2023, where 5.7 million American depositary shares were sold at $6.80 per share.
Investors are encouraged to assist the investigation by visiting bgandg.com/AIXI or contacting the firm. The law firm operates on a contingency fee basis, seeking reimbursement for expenses and attorneys' fees only if successful. Bronstein, Gewirtz & Grossman has a track record of recovering millions for investors in securities fraud class actions and shareholder derivative suits.
Bronstein, Gewirtz & Grossman sta indagando su potenziali richieste contro Xiao-I (NASDAQ: AIXI) per conto degli investitori che hanno acquistato i titoli della società. L'indagine si concentra sul significativo calo del prezzo delle ADS di Xiao-I dalla sua IPO dell'8 marzo 2023, quando sono state vendute 5,7 milioni di azioni di deposito americano a $6.80 per azione.
Gli investitori sono incoraggiati a supportare l'indagine visitando bgandg.com/AIXI o contattando lo studio legale. Lo studio opera su base di commissione contingente, richiedendo il rimborso delle spese e delle spese legali solo in caso di successo. Bronstein, Gewirtz & Grossman ha un comprovato bilancio di recupero di milioni per gli investitori in azioni legate a frodi sui titoli e azioni derivate degli azionisti.
Bronstein, Gewirtz & Grossman está investigando posibles reclamaciones contra Xiao-I (NASDAQ: AIXI) en nombre de los inversores que compraron los valores de la empresa. La investigación se centra en la significativa caída en el precio de las ADS de Xiao-I desde su IPO del 8 de marzo de 2023, cuando se vendieron 5,7 millones de acciones de depósito estadounidense a $6.80 por acción.
Se anima a los inversores a ayudar en la investigación visitando bgandg.com/AIXI o contactando con el bufete. El bufete opera bajo una base de honorarios condicionales, buscando el reembolso de gastos y honorarios de abogados solo si tiene éxito. Bronstein, Gewirtz & Grossman tiene un historial de recuperación de millones para los inversores en acciones de fraude de valores y demandas derivativas de accionistas.
Bronstein, Gewirtz & Grossman은 잠재적인 청구에 대해 조사하고 있습니다 Xiao-I (NASDAQ: AIXI)에 대해 회사의 증권을 구매한 투자자를 대신하여. 이 조사는 Xiao-I의 ADS 가격이 2023년 3월 8일 IPO 이후 급격히 하락한 것에 초점을 맞추고 있으며, 이 날짜에 570만 개의 미국 예탁주식이 주당 $6.80에 판매되었습니다.
투자자들은 bgandg.com/AIXI를 방문하거나 법무법인에 연락하여 조사를 지원하도록 권장됩니다. 이 법무법인은 우선 보수를 기반으로 운영되며, 성공 시에만 비용 및 변호사 수수료를 환불받기 위해 노력합니다. Bronstein, Gewirtz & Grossman은 증권 사기 집단 소송 및 주주 파생 소송에서 투자자를 위해 수백만 달러를 회수한 실적이 있습니다.
Bronstein, Gewirtz & Grossman enquête sur d'éventuelles réclamations contre Xiao-I (NASDAQ: AIXI) au nom des investisseurs ayant acheté les titres de l'entreprise. L'enquête se concentre sur la chute significative du prix des ADS de Xiao-I depuis son introduit en bourse le 8 mars 2023, où 5,7 millions d'actions de dépôts américains ont été vendues à 6,80 $ l'action.
Les investisseurs sont encouragés à soutenir l'enquête en visitant bgandg.com/AIXI ou en contactant le cabinet. Le cabinet travaille sur la base d'honoraires conditionnels, cherchant à se faire rembourser les frais et les honoraires d'avocat uniquement en cas de succès. Bronstein, Gewirtz & Grossman a un historique de récupération de millions pour les investisseurs dans des actions de fraude sur les titres et des actions dérivées des actionnaires.
Bronstein, Gewirtz & Grossman untersucht mögliche Ansprüche gegen Xiao-I (NASDAQ: AIXI) im Namen von Investoren, die die Wertpapiere des Unternehmens erworben haben. Die Untersuchung konzentriert sich auf den erheblichen Rückgang des ADS-Preises von Xiao-I seit dem IPO am 8. März 2023, als 5,7 Millionen amerikanische Depotaktien zu 6,80 $ pro Aktie verkauft wurden.
Investoren werden ermutigt, die Untersuchung zu unterstützen, indem sie bgandg.com/AIXI besuchen oder die Kanzlei kontaktieren. Die Kanzlei arbeitet auf Erfolgsbasis und fordert Erstattung für Ausgaben und Anwaltsgebühren nur im Erfolgsfall. Bronstein, Gewirtz & Grossman hat eine Erfolgsbilanz, Millionen für Investoren in Wertpapierbetrugs-Klageverfahren und Aktionärsklagen zurückzugewinnen.
- None.
- Significant drop in Xiao-I's ADS price since IPO, potentially damaging investors
- Ongoing investigation into potential claims against Xiao-I
- Possible securities fraud or shareholder rights violations
Insights
This investigation into Xiao-I (AIXI) raises significant red flags for investors. The sharp decline in ADS price since the IPO suggests potential material misrepresentations or omissions in the company's disclosures. While the specifics of the alleged wrongdoings are not detailed, such investigations often lead to class action lawsuits and can result in substantial financial penalties.
Investors should be cautious, as this could indicate deeper issues within the company's operations or financial reporting. The involvement of a reputable law firm like Bronstein, Gewirtz & Grossman adds credibility to the concerns. Shareholders may face potential losses and should consider seeking legal advice to understand their rights and possible avenues for compensation.
The investigation into Xiao-I (AIXI) presents a bearish outlook for the stock. The significant drop in ADS price since the IPO, coupled with potential legal troubles, could lead to further downward pressure on the stock. This situation may result in increased volatility and negative sentiment among investors.
From a financial perspective, the company may face substantial legal costs and potential settlements, which could impact its balance sheet and cash flow. Additionally, the distraction of legal proceedings might hinder the company's ability to focus on its core business operations, potentially affecting future growth and profitability. Investors should closely monitor any updates regarding the investigation and consider the heightened risk profile of AIXI stock.
NEW YORK CITY, NY / ACCESSWIRE / August 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Xiao-I Corporation ("Xiao-I" or "the Company") (NASDAQ:AIXI). Investors who purchased Xiao-I securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/AIXI.
Investigation Details
On or around March 8, 2023, Xiao-I conducted its initial public offering ("IPO"), selling 5.7 million American depositary shares ("ADSs") at
What's Next?
If you are aware of any facts relating to this investigation or purchased Xiao-I securities, you can assist this investigation by visiting the firm's site: bgandg.com/AIXI. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View the original press release on accesswire.com
FAQ
What is the purpose of the investigation against Xiao-I (AIXI)?
When did Xiao-I (AIXI) conduct its IPO and at what price?
How can investors participate in the investigation against Xiao-I (AIXI)?
What are the potential costs for investors participating in the investigation against Xiao-I (AIXI)?
